XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.19.2

Stockholders' Equity | 6 Months Ended
--- | ---
Jun. 30, 2019
Stockholders' Equity |
Stockholders' Equity | Note 9 - Stockholders’ Equity Common Stock Under the terms of the Second Amended and Restated Founders Agreement, which became effective July 22, 2016, Fortress will receive a grant of shares of our common stock equal to two and one-half percent (2.5%) of the gross amount of any equity or debt financing. On March 29, 2019, the Company issued 108,069 shares of common stock to Fortress, which equaled 2.5% of the gross funded amount of the Horizon note. The Company recorded an expense of approximately $0.4 million in general and administrative expenses related to these shares during the six months ended June 30, 2019. In April 2019, the Company issued 87,656 shares of common stock to Fortress, which equaled 2.5% of the gross proceeds of $22.5 million from the sale of shares of common stock under Mustang’s At-the-Market offering. The Company recorded an expense of approximately $0.5 million in general and administrative expenses related to these shares during the six months ended June 30, 2019. In May 2019, the Company issued 197,656 shares of common stock to Fortress, which equaled 2.5% of the gross proceeds of $31.6 million from the sale of shares of common stock under Mustang’s underwritten public offering. The Company recorded an expense of approximately $0.8 million in general and administrative expenses related to these shares during the six months ended June 30, 2019. In April 2019, COH converted 137,608 shares of the Company’s Class A common stock to 137,608 shares of the Company’s common stock. Mustang At-the-Market Offering On July 13, 2018, Mustang filed a shelf registration statement No. 333-226175 on Form S-3, as amended on July 20, 2018 (the "Mustang S-3"), which was declared effective in August 2018. Under the Mustang S-3, Mustang may sell up to a total of $75.0 million of its securities. In connection with the Mustang S-3, the Company entered into an At-the-Market Issuance Sales Agreement (the "Mustang ATM") with B. Riley FBR, Inc., Cantor Fitzgerald & Co., National Securities Corporation, and Oppenheimer & Co. Inc. (each an "Agent" and collectively, the "Agents"), relating to the sale of shares of common stock. Under the Mustang ATM, the Company pays the Agents a commission rate of up to 3.0% of the gross proceeds from the sale of any shares of common stock. During the three and six months ended June 30, 2019, the Company issued approximately 3.5 million shares of common stock at an average price of $6.42 per share for gross proceeds of $22.5 million. In connection with these sales, Mustang paid aggregate fees of approximately $0.5 million for net proceeds of approximately $22.0 million. No sales were made under the Mustang ATM in 2018. Mustang Public Offering of Common Stock On April 30, 2019, we announced the pricing of an underwritten public offering, whereby we sold 6,875,000 shares of common stock, (plus a 30-day option to purchase up to an additional 1,031,250 shares of common stock, which was fully exercised) at a price of $4.00 per share for gross proceeds of approximately $31.6 million, before deducting underwriting discounts and commissions and offering expenses. In connection with the public offering, the Company paid aggregate fees of approximately $2.1 million for net proceeds of approximately $29.5 million. The shares were sold under the Mustang S-3, filed with the Securities and Exchange Commission. The offering closed on May 2, 2019, and the over-allotment closing was on May 8, 2019. As of June 30, 2019, approximately $20.9 million of the Mustang S-3 remains available for sales of securities. Stock Awards Stock Options The Company has in effect the 2016 Incentive Plan (the “Incentive Plan”). The Incentive Plan was adopted in 2016 by our stockholders and the compensation committee of the Company’s board of directors and is authorized to grant stock-based awards to directors, officers, employees and consultants. The plan initially authorized grants to issue up to 2,000,000 shares of authorized but unissued common stock, expires 10 years from adoption, and limits the term of each option to no more than 10 years from the date of grant. In June 2018, the Company’s stockholders approved an amendment to the Incentive Plan to increase the number of authorized shares issuable by 3,000,000 shares, for a total of 5,000,000 shares. Total shares available for the issuance of stock-based awards under the Incentive Plan was 1,987,439 shares at June 30, 2019. The following table summarizes stock option activities for the six months ended June 30, 2019:
|  |  |  |  |  | Weighted Average
|  |  |  |  |  | Remaining
|  |  |  | Weighted Average |  | Contractual Life
|  | Stock Options |  | Exercise Price |  | (in years)
Outstanding at December 31, 2018 |  | 1,241,675 |  | $ | 5.73 |  | 8.31
Options granted |  | — |  |  | — |  | —
Outstanding at June 30, 2019 |  | 1,241,675 |  |  | 5.73 |  | 7.81
Options vested and exercisable at June 30, 2019 |  | 310,417 |  | $ | 5.73 |  | 7.81
As of June 30, 2019, the Company had unrecognized stock-based compensation expense related to options of $0.8 million, which is expected to be recognized over the remaining weighted average vesting period of approximately 1.6 years. This amount does not include, as of June 30, 2019, 310,419 stock options outstanding which are performance-based and vest upon achievement of certain corporate milestones. Stock-based compensation for milestone awards will be measured and recorded if and when it is probable that the milestone will be achieved. Restricted Stock The following table summarizes restricted stock award activities for the six months ended June 30, 2019:
|  |  |  | Weighted Average
|  | Number |  | Grant Date
|  | of Shares |  | Fair Value
Nonvested at December 31, 2018 |  | 502,636 |  | $ | 5.76
Granted |  | 50,000 |  |  | 3.80
Nonvested at June 30, 2019 |  | 552,636 |  | $ | 5.58
As of June 30, 2019, the Company had unrecognized stock-based compensation expense related to restricted stock of $1.6 million, which is expected to be recognized over the remaining weighted average vesting period of approximately 2.2 years. This amount does not include, as of June 30, 2019, 68,160 shares of restricted stock outstanding which are performance-based and vest upon achievement of certain corporate milestones. Stock-based compensation for milestone awards will be measured and recorded if and when it is probable that the milestone will be achieved. Restricted Stock Units Certain employees and consultants have been awarded restricted stock units with time-based vesting. The following table summarizes restricted stock units activities for the six months ended June 30, 2019:
|  |  |  |  | Weighted Average
|  | Number |  | Grant Date
|  | of Units |  | Fair Value
Nonvested at December 31, 2018 |  |  | 1,032,084 |  | $ | 7.77
Granted |  |  | 309,000 |  |  | 2.99
Forfeited |  |  | (296,750) |  |  | 7.98
Vested |  |  | (76,000) |  |  | 10.81
Nonvested at June 30, 2019 |  |  | 968,334 |  | $ | 5.94
As of June 30, 2019, the Company had unrecognized stock-based compensation expense related to restricted stock units of approximately $2.9 million, which is expected to be recognized over the remaining weighted average vesting period of approximately 1.9 years. The following table summarizes stock-based compensation expense for the three and six months ended June 30, 2019 and 2018 (in thousands).
|  | For the three months ended June 30, |  | For the six months ended June 30,
|  | 2019 |  | 2018 |  | 2019 |  | 2018
General and administrative |  | $ | 333 |  | $ | 393 |  | $ | 669 |  | $ | 936
Research and development |  |  | 289 |  |  | 578 |  |  | 385 |  |  | 2,030
Total stock-based compensation expense |  | $ | 622 |  | $ | 971 |  | $ | 1,054 |  | $ | 2,966
Warrants A summary of warrant activities for six months ended June 30, 2019 is presented below:
|  |  |  |  |  |  | Weighted Average
|  |  |  |  |  |  | Remaining
|  |  |  | Weighted Average |  | Contractual Life
|  | Warrants |  | Exercise Price |  | (in years)
Outstanding as of December 31, 2018 |  | 5,210,698 |  | $ | 8.32 |  | 3.10
Granted |  | 288,184 |  |  | 3.47 |  | 9.75
Exercised |  | (65,358) |  |  | — |  | —
Outstanding as of June 30, 2019 |  | 5,433,524 |  | $ | 8.16 |  | 2.92
Upon the exercise of warrants, the Company will issue new shares of common stock.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration